We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

10 hedge funds and large institutions have $186K invested in Genetic Technologies Ltd. in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 12 → 10 (-2)

27% less capital invested

Capital invested by funds: $254K → $186K (-$68K)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
4
Closed
5
Calls
$108K
Puts
–
Net Calls
+$108K
Net Calls Change
+$63K

Top Buyers

Rank Fund Capital Flow
1
OMC
Old Mission Capital
Illinois
+$48.9K
2
Millennium Management
Millennium Management
New York
+$8.02K
3
Simplex Trading
Simplex Trading
Illinois
+$664
4
Bank of America
Bank of America
North Carolina
+$365

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$41K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$30.2K
3
GSC
Ground Swell Capital
South Carolina
-$26K
4
TSS
Two Sigma Securities
New York
-$14K
5
UBS Group
UBS Group
Switzerland
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$62K -$292 -40 -0.4%
OMC
2
Old Mission Capital
Illinois
$39K +$48.9K +6,700 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$37K -$30.2K -4,145 -40%
Millennium Management
4
Millennium Management
New York
$25K +$8.02K +1,099 +36%
CA
5
Cetera Advisors
Colorado
$16K -$4.38K -600 -18%
UBS Group
6
UBS Group
Switzerland
$4K -$5K -685 -50%
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.34K – – –
Wells Fargo
8
Wells Fargo
California
$1K – – –
Citadel Advisors
9
Citadel Advisors
Florida
– -$41K -7,223 Closed
GSC
10
Ground Swell Capital
South Carolina
– -$26K -4,533 Closed
TSS
11
Two Sigma Securities
New York
– -$14K -2,336 Closed
CAPTRUST Financial Advisors
12
CAPTRUST Financial Advisors
North Carolina
– -$4K -700 Closed
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
– -$1K -200 Closed
Bank of America
14
Bank of America
North Carolina
– +$365 +50 New
Simplex Trading
15
Simplex Trading
Illinois
– +$664 +91 New

GENE Hedge Fund Activity: Q3 2022 in Review

10 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2022, worth a combined $186K — down 27% from $254K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of GENE and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Old Mission Capital, opening a new position worth an estimated $48.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $41K sold.

  • 10 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2022, down from 12 in Q2 2022.
  • Funds reported $186K of Genetic Technologies Ltd. stock for Q3 2022, down 27% quarter-over-quarter.
  • 3 funds opened new Genetic Technologies Ltd. positions in Q3 2022 and 5 closed out, a net change of -2 holders.
  • The largest Genetic Technologies Ltd. buyer in Q3 2022 was Old Mission Capital, an estimated $48.9K added.
  • The largest Genetic Technologies Ltd. seller in Q3 2022 was Citadel Advisors, an estimated $41K sold.

Based on aggregated 13F filings for Q3 2022.